Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, has announced it has entered into an agreement to acquire the IndivuServ business unit of Indivumed GmbH. A Share Purchase Agreement (SPA) between both parties was executed on December 29, 2022, and subject to customary closing adjustments the transaction is expected to close in April 2023. Indivumed GmbH, founded in Germany in 2002, has an industry-leading and global reputation for the provision and analysis of clinical biospecimens. The transaction will generate two separate Indivumed entities, ‘Indivumed Therapeutics’ and ‘Indivumed Services’.
Read the full article: Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank //
Source: https://www.businesswire.com/news/home/20230125005114/en/Crown-Bioscience-to-Acquire-Indivumed%E2%80%99s-Service-Business-and-Supporting-Biobank